Construct Validity of the Amyotrophic Lateral Sclerosis Bulbar Dysfunction Index–Remote
The ALSBDI-R is a valid tool for remotely assessing bulbar dysfunction in patients with ALS. Despite several limitations, its ability to capture varying degrees of severity makes it valuable for clinical use and research, offering a standardized approach to monitor disease progression remotely.
Authors
- Marc F. Maffei (ORCID: https://orcid.org/0000-0001-6341-1702)
- Yana Yunusova (ORCID: https://orcid.org/0000-0002-2353-2275)
- James D. Berry (ORCID: https://orcid.org/0000-0003-0898-6081)
- Rosemary Martino (ORCID: https://orcid.org/0000-0002-3298-7714)
- Victoria Tilton-Bolowsky (ORCID: https://orcid.org/0000-0003-1752-6693)
- Lorne Zinman (ORCID: https://orcid.org/0000-0002-8096-8366)
- Agessandro Abrahão (ORCID: https://orcid.org/0000-0003-1142-2842)
- Liziane Bouvier (ORCID: https://orcid.org/0000-0002-7239-7639)
- Timothy Pommée (ORCID: https://orcid.org/0000-0001-7846-7282)
- Carolina Barnett (ORCID: https://orcid.org/0000-0001-5546-0221)
- Sarah E. Gutz (ORCID: https://orcid.org/0000-0002-1601-0639)
- Jordan R. Green (ORCID: https://orcid.org/0000-0002-1464-1373)
Institutions
- Boston University (US)
- Sunnybrook Health Science Centre (CA)
- University Health Network (CA)
- Harvard University (US)
- MGH Institute of Health Professions (US)
- University of Toronto (CA)
- Toronto Rehabilitation Institute (CA)
- Health Sciences Centre (CA)
- Massachusetts General Hospital (US)
- Public Health Ontario (CA)
- Krembil Research Institute
- Sunnybrook Research Institute
Publication Details
- Journal
- American Journal of Speech-Language Pathology
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1044/2025_ajslp-24-00489
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00